Imiquimod, TLR7 ligand (4-Amino-1-isobutyl-1H-imidazo (4,5-c) quinoline)
|Amount :||5 mg|
|Purification :||Purity: ≥98%|
|Content :||5 mg/ml in DMSO|
|Storage condition :||Stable for 2 years in compound form and Stock solutions are stable for 3 months at -20°C. Can be stored at 4°C for short term.|
Identity: Determined by IR.
Appearance: White to off-white powder.
Solubility: Soluble in DMSO or dimethylformamide. Insoluble in ethanol. Slightly soluble in water.
Immune response modulator, Anti-inflammatory, TLR7 agonist, Stimulates proinflammatory cytokine production interferon-α (IFN-α), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) and activates NF-κB, Caspase-3 activator that directly induces procaspase-3 cleavage, Anti-cancer compound
For Research Use Only. Not for use in diagnostic/therapeutics procedures.